Table 1 National survivorship care survey participant characteristics
Characteristic | n = 1278 |
|---|---|
Age, M | |
Mean | 64 |
Gender, N (%) | |
female | 719 (56.3) |
Cancer site, N (%) | |
Breast | 679 (53.1) |
Prostate | 451 (35.3) |
Colorectal | 148 (11.6) |
Stage at diagnosis, N (%) | |
Stage 0 | 157 (12.3) |
Stage 1 | 385 (30.1) |
Stage 2 | 227 (17.8) |
Stage 3 | 227 (9.8) |
Stage 4 | 36 (2.8) |
Don’t Know | 345 (31) |
Time since cancer diagnosis, N (%) | |
<1 year | 38 (3.0) |
1-10 years | 800 (62.7) |
11-20 years | 341 (26.7) |
21-30 years | 79 (6.2) |
31-40 years | 16 (1.3) |
41-50 years | 2 (0.0) |
Treatment, N (%) | |
Surgery | 1033 (80.8) |
Chemotherapy | 433 (33.9) |
Radiation | 637 (49.8) |
Hormonal therapy | 398 (31.1) |
Other | 81 (6.3) |
Race, N (%) | |
White | 1099 (86) |
Black | 63 (4.9) |
Other | 50 (3.9) |
Hispanic ethnicity, N (%) | |
yes | 66 (6.2) |
Insurance status N (%) | |
yes | 1259 (98.5) |
Insurance type | |
Private | 642 (50.2) |
Medicare | 783 (61.3) |
Medicare supplement | 389 (30.4) |
Medicaid | 85 (6.7) |
Other | 54 (4.2) |